Powerful analytics can decrease timelines and enhance process robustness, but also provide a deeper understanding of the impact of process steps on product quality.
TORONTO, Ontario (PRWEB) April 28, 2021
Development of innovative biologics therapy is challenging due to molecular complexity, time intensive processes, and high failure rate in process development and in the clinic, making the process long and expensive.
Deeper knowledge of the physiochemical properties biologics can aid in decision-making early in development and help inform improvements during the transition from discovery to the biologics license application (BLA). This webinar will detail improvements we have implemented during our development process and focus on the benefits of an appropriate analytical toolkit to fit the needs of the biologic and process being developed.
We will demonstrate the benefit of monitoring critical attributes that have the potential to impact stability, function or appearance in the final product. Our approach gains the most benefit by using this analytical toolkit during the early process development stages. We will highlight a few key examples where monitoring proves to be most impactful in the process, for example in cell line development or downstream process development.
Powerful analytics can decrease timelines and enhance process robustness, but also provide a deeper understanding of the impact of process steps on product quality. By the end of the webinar, we will have demonstrated that selecting key product attributes and monitoring those attributes through process development can have a major impact on the product quality.
Join Christa Feasley, PhD, Senior Analytical Development Scientist, Cytovance Biologics in a live webinar on Wednesday, May 19, 2021 at 12pm EDT to learn about how using those key attributes to monitor the processes under development can decrease timelines, improve product quality, reduce cost and enable the implementation of key knowledge gained from a well-informed analytical toolkit including MS technology.
For more information, or to register for this event, visit Accelerating Biologics Drug Development with an Expanding Analytical Toolkit.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.